Concord Medical Services (CCM) Stock Price, News & Analysis

Company Overview

Concord Medical Services Holdings Limited is one of China’s leading providers of radiation oncology services, offering comprehensive cancer treatment solutions through partnerships with public hospitals. Founded in 2006 and listed on the New York Stock Exchange in 2017 under the ticker CCM, the company develops, equips and operates modern radiotherapy centers across mainland China. Concord Medical’s model integrates capital investment, clinical expertise and high‐precision technology to expand access to radiotherapy in cities where advanced oncology services have historically been limited.

The company’s core services include the design, construction and operation of radiation oncology centers, equipment procurement and installation, routine maintenance, clinical physics support and staff training. Utilizing a range of advanced platforms—such as intensity‐modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), image‐guided radiotherapy (IGRT) and brachytherapy—Concord Medical delivers tailored treatment plans, quality assurance and remote dosimetry through a centralized planning platform. These integrated services help hospital partners enhance patient throughput and improve treatment outcomes.

Concord Medical has established a network of over sixty oncology centers spanning more than twenty provinces, predominantly serving tier‐2 and tier‐3 cities. The company’s franchise‐style collaborations with leading public hospitals allow rapid scaling while maintaining consistent clinical protocols and operational standards. By leveraging shared resources and a proprietary information system, Concord Medical provides streamlined workflows and data analysis tools that support clinical decision making and optimize utilization of radiotherapy equipment.

Governed by a management team with deep experience in healthcare, finance and oncology, Concord Medical is guided by a co‐founder and chairman who has led the company since inception, alongside a chief executive officer with a background in clinical operations and research. Supported by a board that includes senior medical experts, the company continues to expand its footprint, pursuing strategic partnerships and new technologies to address the growing demand for high‐quality cancer care in China.

Key Stats

• Today's Range: $5.20 to $5.25
• 50-Day Range: $5.20 to $8.71
• 52-Week Range: $3.80 to $10.50
• Volume: 657 shs
• Average Volume: 16,210 shs
• Market Capitalization: $24.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Concord Medical Services Stock Analysis - MarketRank™

Concord Medical Services scored higher than 16% of companies evaluated by MarketBeat, and ranked 869th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Concord Medical Services.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Concord Medical Services has a P/B Ratio of 0.11. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.06% of the float of Concord Medical Services has been sold short.

Short Interest Ratio / Days to Cover

Concord Medical Services has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Concord Medical Services has recently decreased by 22.22%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Concord Medical Services does not currently pay a dividend.

Dividend Growth

Concord Medical Services does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.06% of the float of Concord Medical Services has been sold short.

Short Interest Ratio / Days to Cover

Concord Medical Services has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Concord Medical Services has recently decreased by 22.22%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 3 news articles for Concord Medical Services this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Concord Medical Services insiders have not sold or bought any company stock.

Percentage Held by Insiders

46.50% of the stock of Concord Medical Services is held by insiders. A high percentage of insider ownership can be a sign of company health.

CCM Stock Analysis - Frequently Asked Questions

How have CCM shares performed this year?

Concord Medical Services' stock was trading at $5.38 on January 1st, 2025. Since then, CCM stock has increased by 4.1% and is now trading at $5.60.

How were Concord Medical Services' earnings last quarter?

Concord Medical Services Holdings Limited (NYSE:CCM) issued its quarterly earnings results on Wednesday, August, 24th. The company reported ($0.60) earnings per share (EPS) for the quarter, missing the consensus estimate of $2.10 by $2.70. The firm earned $18.93 million during the quarter.

When did Concord Medical Services' stock split?

Concord Medical Services shares reverse split before market open on Tuesday, July 30th 2024.The 1-10 reverse split was announced on Tuesday, July 30th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, July 30th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Concord Medical Services?

Shares of CCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Concord Medical Services own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Concord Medical Services investors own include M&T Bank (MTB), Carlyle Group (CG), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD), Crescent Biopharma (CBIO) and Chevron (CVX).

Company Calendar

• Last Earnings: 8/24/2016
• Today: 7/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - NURSING HMS
• Sub-Industry: Healthcare
• Current Symbol: NYSE:CCM
• CIK: 1472072
• Web: www.concordmedical.com
• Phone: 861059036688
• Fax: 86-10-5957-5252
• Employees: 970
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.67
• Current Ratio: 0.46
• Quick Ratio: 0.45

Sales & Book Value

• Annual Sales: $52.60 million
• Price / Sales: 0.46
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $51.05 per share
• Price / Book: 0.11

Miscellaneous

• Outstanding Shares: 4,340,000
• Free Float: 2,323,000
• Market Cap: $24.30 million
• Optionable: Not Optionable
• Beta: -0.90